Clinical Trial Update: Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating DWJ211 for treating submental fat has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• DWJ211

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Treatment for Submental Fat | Phase 2 | Status: COMPLETED